Lv64
2028 积分 2024-11-25 加入
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
38分钟前
已完结
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
3小时前
已完结
Pharmacodynamic model of tolerance: application to nicotine
1个月前
已完结
Putting Pharmacokinetics and Pharmacodynamics to Work in Drug Discovery
2个月前
已完结
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
2个月前
已完结
A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer
2个月前
已关闭
Septal LYVE1(+) macrophages control adipocyte stem cell adipogenic potential
3个月前
已完结
An evaluation of odronextamab for the treatment of multiple subtypes of relapsed/refractory B-cell non-hodgkin lymphoma
3个月前
已完结
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
3个月前
已完结
Oncology Combination Drug Development Strategies for Project Optimus
4个月前
已完结
皖公网安备34019202002308
